The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes

Journal of Immunology

Volumn 190, Issue 3, 2013, Pages 961-969

  Stumpf, Melanie ^b   Zhou, Xuyu ^c   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; ISOPROTEIN; LIGAND; MESSENGER RNA; PROTEIN B7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL ARTIFICIAL CHROMOSOME; BIOENGINEERING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; EMBRYO; EXON; GENE DELETION; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LIGAND BINDING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENE;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; EXONS; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; PREDIABETIC STATE; PROTEIN ISOFORMS; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, REGULATORY;

EID: 84872744448     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201362     Document Type: Article

References (55)

1. Bour-Jordan, H., J. H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J. A. Bluestone. 2011. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 241: 180-205.
2. Fife, B. T., and J. A. Bluestone. 2008. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev. 224: 166-182.
3. Scalapino, K. J., and D. I. Daikh. 2008. CTLA-4: A key regulatory point in the control of autoimmune disease. Immunol. Rev. 223: 143-155. (Pubitemid 351986184)
4. Gough, S. C., L. S. Walker, and D. M. Sansom. 2005. CTLA4 gene polymorphism and autoimmunity. Immunol. Rev. 204: 102-115. (Pubitemid 40460496)
5. Holmberg, D., C. M. Cilio, M. Lundholm, and V. Motta. 2005. CTLA-4 (CD152) and its involvement in autoimmune disease. Autoimmunity 38: 225-233. (Pubitemid 40959896)
6. Ghaderi, A. 2011. CTLA4 gene variants in autoimmunity and cancer: A comparative review. Iran. J. Immunol. 8: 127-149.
7. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
8. Waterhouse, P., J.M. Penninger, E. Timms, A.Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985-988.
9. Chikuma, S., J. B. Imboden, and J. A. Bluestone. 2003. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 197: 129-135. (Pubitemid 36110264)
10. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183: 2541-2550. (Pubitemid 26192364)
11. Luhder, F., C. Chambers, J. P. Allison, C. Benoist, and D. Mathis. 2000. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc. Natl. Acad. Sci. USA 97: 12204-12209.
12. Chikuma, S., and J. A. Bluestone. 2003. CTLA-4 and tolerance: The biochemical point of view. Immunol. Res. 28: 241-253. (Pubitemid 38091062)
13. Balzano, C., N. Buonavista, E. Rouvier, and P. Golstein. 1992. CTLA-4 and CD28: Similar proteins, neighbouring genes. Int. J. Cancer Suppl. 7: 28-32.
14. Howard, T. A., J. M. Rochelle, and M. F. Seldin. 1991. Cd28 and Ctla-4, two related members of the Ig supergene family, are tightly linked on proximal mouse chromosome 1. Immunogenetics 33: 74-76.
15. Pentcheva-Hoang, T., J. G. Egen, K. Wojnoonski, and J. P. Allison. 2004. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21: 401-413. (Pubitemid 39208341)
16. Saito, T., T. Yokosuka, and A. Hashimoto-Tane. 2010. Dynamic regulation of T cell activation and co-stimulation through TCR-microclusters. FEBS Lett. 584: 4865-4871.
17. Yokosuka, T., W. Kobayashi, M. Takamatsu, K. Sakata-Sogawa, H. Zeng, A. Hashimoto-Tane, H. Yagita, M. Tokunaga, and T. Saito. 2010. Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 33: 326-339.
18. Baroja, M. L., L. Vijayakrishnan, E. Bettelli, P. J. Darlington, T. A. Chau, V. Ling, M. Collins, B. M. Carreno, J. Madrenas, and V. K. Kuchroo. 2002. Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol. 168: 5070-5078. (Pubitemid 34495970)
19. Rudd, C. E., A. Taylor, and H. Schneider. 2009. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 229: 12-26.
20. Chuang, E., T. S. Fisher, R. W. Morgan, M. D. Robbins, J. M. Duerr, M. G. Vander Heiden, J. P. Gardner, J. E. Hambor, M. J. Neveu, and C. B. Thompson. 2000. The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity 13: 313-322.
21. Marengere, L. E., P. Waterhouse, G. S. Duncan, H. W. Mittrucker, G. S. Feng, and T. W. Mak. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272: 1170-1173. (Pubitemid 26169471)
22. Lee, K. M., E. Chuang, M. Griffin, R. Khattri, D. K. Hong, W. Zhang, D. Straus, L. E. Samelson, C. B. Thompson, and J. A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282: 2263-2266. (Pubitemid 29004076)
23. Guntermann, C., and D. R. Alexander. 2002. CTLA-4 suppresses proximal TCR signaling in resting human CD4+ T cells by inhibiting ZAP-70 Tyr319 phosphorylation: A potential role for tyrosine phosphatases. J. Immunol. 168: 4420-4429. (Pubitemid 34441343)
24. Calvo, C. R., D. Amsen, and A. M. Kruisbeek. 1997. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor z and ZAP70. J. Exp. Med. 186: 1645-1653. (Pubitemid 27506278)
25. Chuang, E., K. M. Lee, M. D. Robbins, J. M. Duerr, M. L. Alegre, J. E. Hambor, M. J. Neveu, J. A. Bluestone, and C. B. Thompson. 1999. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J. Immunol. 162: 1270-1277. (Pubitemid 29306995)
26. Schneider, H., D. A. Mandelbrot, R. J. Greenwald, F. Ng, R. Lechler, A. H. Sharpe, and C. E. Rudd. 2002. Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signalregulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ ligand-deficient mice. J. Immunol. 169: 3475-3479.
27. Tai, X., F. Van Laethem, L. Pobezinsky, T. Guinter, S. O. Sharrow, A. Adams, L. Granger, M. Kruhlak, T. Lindsten, C. B. Thompson, et al. 2012. Basis of CTLA-4 function in regulatory and conventional CD4+ T cells. Blood 119: 5155-5163.
28. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511. (Pubitemid 36648570)
29. Vijayakrishnan, L., J. M. Slavik, Z. Illés, D. Rainbow, L. B. Peterson, A. S. Sharpe, L. S. Wicker, and V. K. Kuchroo. 2005. An autoimmune diseaseassociated CTLA4 splice variant lacking the B7 binding domain signals negatively in T cells. Novartis Found. Symp. 267: 200-212, discussion 212-218.
30. Howson, J.M., D. B. Dunger, S. Nutland, H. Stevens, L. S.Wicker, and J. A. Todd. 2007. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 50: 741-746. (Pubitemid 46355837)
31. Nistico, L., R. Buzzetti, L. E. Pritchard, B. Van der Auwera, C. Giovannini, E. Bosi, M. T. Larrad, M. S. Rios, C. C. Chow, C. S. Cockram, et al. 1996. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5: 1075-1080. (Pubitemid 26232296)
32. Hill, N. J., P. A. Lyons, N. Armitage, J. A. Todd, L. S. Wicker, and L. B. Peterson. 2000. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49: 1744-1747.
33. Wicker, L. S., G. Chamberlain, K. Hunter, D. Rainbow, S. Howlett, P. Tiffen, J. Clark, A. Gonzalez-Munoz, A. M. Cumiskey, R. L. Rosa, et al. 2004. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173: 164-173. (Pubitemid 38797338)
34. Araki, M., D. Chung, S. Liu, D. B. Rainbow, G. Chamberlain, V. Garner, K. M. Hunter, L. Vijayakrishnan, L. B. Peterson, M. Oukka, et al. 2009. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. J. Immunol. 183: 5146-5157.
35. Perkins, D., Z. Wang, C. Donovan, H. He, D. Mark, G. Guan, Y. Wang, T. Walunas, J. Bluestone, J. Listman, and P. W. Finn. 1996. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156: 4154-4159. (Pubitemid 26165810)
36. Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J. A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
37. de Boer, J., A. Williams, G. Skavdis, N. Harker, M. Coles, M. Tolaini, T. Norton, K. Williams, K. Roderick, A. J. Potocnik, and D. Kioussis; de. 2003. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33: 314-325. (Pubitemid 36267595)
38. Bour-Jordan, H., B. L. Salomon, H. L. Thompson, R. Santos, A. K. Abbas, and J. A. Bluestone. 2007. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse. J. Immunol. 179: 1004-1012.
39. Gerold, K. D., P. Zheng, D. B. Rainbow, A. Zernecke, L. S. Wicker, and S. Kissler. 2011. The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function. Diabetes 60: 1955-1963.
40. Lamhamedi-Cherradi, S. E., O. Boulard, C. Gonzalez, N. Kassis, D. Damotte, L. Eloy, G. Fluteau, M. Lévi-Strauss, and H. J. Garchon. 2001. Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice. Diabetes 50: 2874-2878. (Pubitemid 33733142)
41. Sugimoto, N., T. Oida, K. Hirota, K. Nakamura, T. Nomura, T. Uchiyama, and S. Sakaguchi. 2006. Foxp3-dependent and-independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18: 1197-1209. (Pubitemid 44349295)
42. Thornton, A. M., P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray, Y. Belkaid, and E. M. Shevach. 2010. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184: 3433-3441.
43. Stadinski, B. D., T. Delong, N. Reisdorph, R. Reisdorph, R. L. Powell, M. Armstrong, J. D. Piganelli, G. Barbour, B. Bradley, F. Crawford, et al. 2010. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11: 225-231.
44. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100. (Pubitemid 23289465)
45. Masteller, E. L., M. R. Warner, Q. Tang, K. V. Tarbell, H. McDevitt, and J. A. Bluestone. 2005. Expansion of functional endogenous antigen-specific CD4+ CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175: 3053-3059. (Pubitemid 41170524)
46. Meagher, C., Q. Tang, B. T. Fife, H. Bour-Jordan, J. Wu, C. Pardoux, M. Bi, K. Melli, and J. A. Bluestone. 2008. Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J. Immunol. 180: 7793-7803.
47. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465. (Pubitemid 38780401)
48. Chikuma, S., A. K. Abbas, and J. A. Bluestone. 2005. B7-independent inhibition of T cells by CTLA-4. J. Immunol. 175: 177-181. (Pubitemid 40884315)
49. Zhou, X., L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone. 2008. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205: 1983-1991.
50. Bour-Jordan, H., and J. A. Bluestone. 2009. Regulating the regulators: Costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 229: 41-66.
51. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
52. Tang, Q., E. K. Boden, K. J. Henriksen, H. Bour-Jordan, M. Bi, and J. A. Bluestone. 2004. Distinct roles of CTLA-4 and TGF-b in CD4+CD25+ regulatory T cell function. Eur. J. Immunol. 34: 2996-3005. (Pubitemid 39549379)
53. Collison, L. W., and D. A. Vignali. 2008. Interleukin-35: Odd one out or part of the family? Immunol. Rev. 226: 248-262.
54. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat. Immunol. 9: 239-244. (Pubitemid 351267321)
55. Peggs, K. S., S. A. Quezada, C. A. Chambers, A. J. Korman, and J. P. Allison. 2009. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 206: 1717-1725.